TriSalus Life Sciences Inc. (TLSIW) financials · rev $45.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
TriSalus Life Sciences Inc. (TLSIW) rev $45.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $45.2M | $29.4M |
| Cost of Revenue | $6.96M | $4.10M |
| Gross Profit | $38.2M | $25.3M |
| Operating Income | -$26.9M | -$36.2M |
| Net Income | -$39.2M | -$30.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $35.3M | $24.0M |
| Current Assets | $32.2M | $20.7M |
| Cash & Equivalents | $20.4M | $8.53M |
| Inventory | $3.08M | $4.05M |
| Total Liabilities | $69.2M | $49.9M |
| Current Liabilities | $11.5M | $10.2M |
| Long-term Debt | $33.0M | $22.1M |
| Total Debt | $33.0M† | $22.1M† |
| Shareholders' Equity | -$33.9M | -$25.9M |
| Retained Earnings | -$330.6M | -$279.5M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$18.0M | -$40.8M |
| CapEx | $918.0K | $345.0K |
| Investing Cash Flow | -$838.0K | -$345.0K |
| Financing Cash Flow | $30.8M | $37.9M |
| Net Change in Cash | $11.9M | -$3.25M |
| Free Cash Flow | -$18.9M | -$41.2M |
FAQ
What is TLSIW P/E and revenue?
TriSalus Life Sciences Inc. (TLSIW) rev $45.2M.
What is TLSIW revenue?
TriSalus Life Sciences Inc. last cached revenue is $45.2M (FY2025).
Is TLSIW profitable?
TriSalus Life Sciences Inc. last cached net income is -$39.2M (FY2025).
What are TLSIW total assets?
TriSalus Life Sciences Inc. last cached total assets are $35.3M (FY2025).
What is TLSIW free cash flow?
TriSalus Life Sciences Inc. last cached free cash flow is -$18.9M (FY2025).
Not investment advice. Cached statements, not a live tape.